Efficacy Study of a Cosmetic Lotion in the Treatment of Androgenetic Alopecia in Males and Females

Mexis George20 enrolled

Overview

The purpose of this study is to determine whether the Hair Loss Prevention Lotion named MEXIS, M.P.A.F., M6S PATENT is effective in the treatment of Androgenetic Alopecia.

This study verifies whether the tested product has any efficacy in the treatment of Androgenetic Alopecia. * The evaluated product (Hair Loss prevention Lotion) is called:MEXIS, MPAF, M6S PATENT. * 20 volunteers both men and women suffering from hair loss both in parties and over the entire scalp with age between 18 and 70 years have been selected for this test . * Samples of the product have been applied following their usual use: as they are. * On the selecting volunteers have been used: 1. The pull test by pulling with fingers of some hair and counting them to estimate the evolution of the pathology. 2. A sebum-meter to check the presence of scales on the scalp. 3. A polarized light video-camera to check the redness of the scalp and to have a picture of hair and scalp. * Volunteers were also asked about: * Fluffiness * Sheen * Itching * Presence of scales on scalp * Oily hair * Product's acceptability * The readings are taken at 0 time (basal value), after 15 days (t15), 30 days (t30), 45 days (t45), 45 days (t45), 60 days (t60) and 90 days (t90) by the experimenter in the medical studio. Then they analyzed and reported in a graph. * Summarizing tables and graphs of the data were taken during experimentation.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Androgenetic Alopecia

Interventions

Hair loss prevention lotionOTHER

For greatest problems 20 drops on the scalp per day for 3 months. For minor problems 10 drops on the scalp three times per week for 3 months.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Good state of general health * Suffering from hair loss * No pharmacological treatment in progress * Promise not to change the usual daily routine * No atopy in the anamnesis Exclusion Criteria: * Illness * Good state of hair * Pharmacological treatment in progress * Denial of the continuance of the usual daily routine * Atopy in the anamnesis

Locations (1)

George Mexis

Athens, Greece

Outcomes

Primary Outcomes

Change of the Amount of Hair Loss in a Pull Test

Measurement of the decrease of hair loss by pull test and pulling some hair with the fingers. Measurements estimated and reported every 15 days. The Measure reports decrease in fallen hair

Time frame: baseline and 90 days

Change of the Density of the Hair on a Polarized Light Video-camera as a Measure of Efficacy.

Number of hair was assessed for each participant with a polarized light video-camera every 15 days for a total of 6 assessments

Time frame: baseline and 90 days

Secondary Outcomes

Change of Sebum on a Sebum-meter

Measurements checked and reported every 15 days of the decrease of existing sebum on the scalp of the volunteers with a sebum-meter.

Time frame: baseline and 90 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.